# Grace Therapeutics Inc.

Organization · id `cardio:org-grace-therapeutics-inc` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Grace+Therapeutics+Inc.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 4 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Grace Therapeutics Inc.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: TRIal For Efficacy of Capre on hyperTriglyceridemiA (`cardio:ct-nct01455844`)
- Sponsors: Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia (`cardio:ct-nct01516151`)
- Sponsors: A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2) (`cardio:ct-nct03361501`)
- Sponsors: A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1) (`cardio:ct-nct03398005`)

## Provenance

Content hash: c8c5c26db78b7b9b72cee8c84dd7af9d1a07463e956dd8aa98fd3fa4623aa958
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
